BACKGROUND: Ghrelin, a 28 amino-acid peptide secreted primarily from the stomach has been identified as the endogenous ligand for the growth hormone secretagogue receptor. Ghrelin is suppressed in the postprandial state and has been linked to both type II diabetes and obesity. AIMS: To investigate the effects of a period of overfeeding with high-fat dietary supplements on plasma ghrelin levels in nonobese men. METHODS: Six healthy males (21-34 y; BMI 21-24 kg/m 2 ) underwent the dietary intervention after completing diet and exercise diaries for 7 days. For 3 further weeks subjects followed their own diet diary supplemented with 125 ml single cream and 50 g roasted peanuts (88 g fat, 15 g Protein, 8 g carbohydrate) every day. Oral fat tolerance tests (OFTT) were undertaken at baseline, 7, 14 and 21 days of fat supplementation. The diet was increased in energy by 3.9 MJ/day and from a mean of 29-45% energy intake from fat with a small weight gain noted each week (P ¼ 0.009). RESULTS: Ghrelin concentrations were significantly reduced during the baseline OFTT. The postprandial ghrelin response (AUC) was significantly reduced following 2 weeks of dietary supplementation (P ¼ 0.005) increasing the suppression of plasma ghrelin by 18% despite only a 3% increase in body weight. Plasma triacylglycerol (P ¼ 0.009) and leptin (P ¼ 0.035) concentrations were also elevated and postprandial pancreatic polypeptide levels decreased (P ¼ 0.038) following dietary-supplementation. CONCLUSIONS: These results suggest that the metabolic profile associated with obesity, including a reduction in plasma ghrelin levels, may be related to recent dietary energy intake and precedes the development of significant adiposity.
Introduction
Obesity and related disorders are among the leading causes of morbidity and mortality in the Western World 1 yet, there is compelling evidence that body weight and body fat levels are well regulated in both animal and humans. 2 Feeding behaviour is modulated by the expression of orexigenic peptides in the hypothalamus, 3 and dysregulation of these central pathways may be important in the development of obesity. In the short-term, mechano-and chemo-receptors signalling the presence and energy density of food within the gastrointestinal (GI) tract may contribute to satiety in the postprandial period. Ghrelin, an endogenous ligand for the GH secretagogue receptor has recently been characterized from extracts of rat stomach 4 and ghrelin immunoreactive neurons have been localized adjacent to the 3rd ventricle with the central effects mediated through neuropeptide Y. 5 Intravenous and central administration of ghrelin stimulates hunger and food intake 5, 6 and levels are decreased in obese subjects 7 which is believed to be an adaptation to reduce hunger and food intake in those with excessive energy balance; however, unlike leptin which is released directly from adipose tissue stores, the signal relaying the body fat stores to the ghrelin releasing X/A cells of the stomach is not clear. High-fat, energy dense foods are thought to be of primary importance in the development of obesity 8 with digestive functions adapting to the proportion of fat in the diet. 9, 10 Recent studies have clearly demonstrated that a low-fat weight-reducing diet does not produce the expected elevations in plasma ghrelin levels 11 but as yet the effects of a high-fat weight gain diet are unknown. Obesity can be achieved by only a small positive energy balance, occurring repeatedly over a long time period. In this study, we have supplemented the diet of healthy lean young men with a moderate amount of fat-rich food (3.9 MJ/day) in order to achieve only a small weight gain which we are using to model the metabolic changes which would occur during the development of obesity rather than when obesity is well established.
Methods

Subjects
Six healthy male subjects were recruited from the student population for this pilot study; mean age 27 y (21-34), mean BMI 22.2 kg/m 2 (21.4-24.3). Subjects had no history of gastrointestinal, endocrine, cardiothoracic or psychiatric disease and were currently not taking any prescribed medication. All medical histories were confirmed with the subjects' general practitioner prior to inclusion in the study. For a period of 1 week, subjects were required to keep a diet and exercise record and were excluded if they consumed more than 35% of their total energy as fat. The protocol was approved by the South Sheffield Ethics Committee and written informed consent was obtained from all subjects.
General protocol
Subjects visited the laboratory for eight experimental visits over a period of 3 weeks, four for postprandial fat-loading tests and four for the measurement of gastric emptying by double sampling gastric aspiration.
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Postprandial test day In order to reduce variability, subjects were provided with a low-fat evening meal (beans on toast) to eat at 1900 h then asked to fast from 2100 h the evening before the test and to refrain from both alcohol and exercise for 24 h. On the test morning, an indwelling retrograde cannula was inserted into the back of the hand and heated to provide arterialised venous blood samples. An oral fat tolerance test (OFTT) 13 consisting of 125 ml dairy cream (60.0 g fat, 3.3 g carbohydrate, 2311 kJ) was administered and blood samples were taken at 30 min intervals for 2 h and then at 4 and 6 h postprandially.
Gastric empting measurement
As with the postprandial test day, subjects were provided with a low-fat evening meal (beans on toast) to eat at 1900 h then asked to fast from 2100 h the evening before the test and to refrain from both alcohol and exercise for 24 h. On waking, subjects consumed 500 ml of water and upon arrival in the unit subjects were seated and a nasogastric tube was positioned (Silicone gastro-duodenal tube CH 14, Vygon Ltd, UK). A 300 ml Intralipid (Pharmacia, UK) containing 25 mg/l phenol red (Sigma-Aldrich, Dorset, UK) was warmed to 371C before being injected into the stomach over a period of 2 min. The contents of the stomach were then mixed by aspiration and reinjecting 20-30 ml, 10 times using a 60 ml catheter tip syringe (Becton-Dickinson, UK). A 2.5 ml sample of stomach contents was aspirated and 5 ml of concentrated marker (500 mg/l phenol red) was added. The procedure of mixing, sampling and adding phenol red dye, mixing and sampling continued on a 10 min cycle for 60 min. 12 The dilution of the dye from the initial drink to the first sample allowed a measurement of the residual volume of the stomach to be made. Phenol red dye is poorly absorbed by the stomach which allows measurements of the dye concentration to be used to calculate the total volume of the liquid within the stomach, the volume of the original drink remaining in the stomach and the volume of secretions within the stomach. Stomach samples were diluted (1:20) with an alkaline buffer (NaOH:NaHCO 2 ; 0.25:0.5 mol/l) before being measured spectrophotometrically (Cecil 2020, Cecil Instruments Cambridge, UK) at 560 nm.
Supplementation
Following the initial OFTT and gastric emptying tests, subjects were provided with a high-fat dietary supplement (125 ml cream and 50 g roasted peanuts; 88 g fat, 14.8 g, protein and 7.6 g carbohydrate) to be eaten each day for 3 weeks. Subjects were also instructed to follow their own diet and exercise diaries as closely as possible (completed during the run-in week). Subjects were asked to return the empty food pots with any uneaten food as a measure of compliance and body weight was monitored at weekly intervals. Assuming an excess in energy intake of 3.9 MJ/day, we would expect a weight gain of approximately 2.5 kg over the 4 week period (assuming storage of excess energy as body fat). This compares well to the mean weight gain of 2.1 kg achieved. Subjects returned to the patient testing suite at the Royal Hallamshire Hospital at 7, 14 and 21 days after the start of the fat supplementation for a further OFTT and on days 8, 15 and 22 for gastric empting measurements.
Blood collection and analytical methods
Blood samples were collected into lithium heparin coated tubes (Sarstedt, Leicester, UK) for the analysis of plasma nonesterified fatty acids (NEFA), 3-hydroxybutyrate (3-OHB) and triacylglycerol (TG). Plasma for the measurement of pancreatic polypeptide (PP), leptin and total ghrelin was collected into potassium EDTA coated tubes containing 200 KIU aprotinin/ml whole blood (Bayer plc, Newbury, UK). Plasma NEFA (Roche) and TG (Biostat) concentrations were measured using enzymatic colorimetric methods on an IL-Monarch (Instumentation Laboratory, Warrington, UK) using commercially available kits. Plasma for 3-OHB Ghrelin and overfeeding MD Robertson et al determination was deproteinized with 7% (wt/vol) perchloric acid and concentrations measured by enzymatic methods. The intra-assay CVs for all metabolite assays were less than 2%. Plasma PP (Eurodiagnostica, Boldon, UK ) total ghrelin and leptin (Linco, MO, USA) were analysed in duplicate using commercially available radioimmunoassays undertaken directly on unextracted plasma. For ghrelin, radioimmunoassay antibodies were raised against the C-terminal region (acylated and des-acylated ghrelin) and showed no detectable cross-reactivity with motilin-related peptide. The sensitivity of this assay was 10 pg/ml. The intra-and interassay CVs for all RIAs were less than 10%.
Statistical analysis
Time course data were analysed by repeated measures ANOVA when normally distributed using SPSS (SPSS Inc, Chicago, USA). Post-hoc tests between adjacent studies, that is, baseline vs week 1, week 1 vs week 2 and week 2 vs week 3 were examined using the least-squares difference method. The postprandial data are also presented in tables, text and figures in summary form, that is, fasting and area under the curve (AUC) with AUC values calculated using the trapezoid rule.
14 Summary data were analysed by paired Student's t- . When the diet diaries for the 3-week supplementation period was examined, the mean nutrient intake (not including dietary supplement itself) did not differ significantly from the nutrient intakes reported during the 7-day run-in period. The diet was changed from a mean energy consumption of 11.8 MJ (29% fat) to 15.7 MJ (45% fat) per day during the 3-week dietary supplementation.
Gastric emptying
Following dietary supplementation the half-emptying time (T 50 ) showed a decrease with each week with significance reached after 2 weeks of supplementation (P ¼ 0.045). The gastric lag time was also significantly decreased after 2 weeks on the supplements (P ¼ 0.005) and the total volume emptied within the hour of the study was also increased ( Table 2 ).
Hormones
The plasma ghrelin level was suppressed during the OFTT on each study visit. There was no effect of dietary supplementation on the fasting ghrelin concentration; however, the postprandial AUC was significantly reduced between 1 and 2 weeks of supplementation (P ¼ 0.005) (Figure 1 ) indicating the inhibitory response of ghrelin to oral fat was enhanced after a period of overfeeding. The timing of ghrelin suppression was also influenced by supplementation. In the baseline study, the maximal suppression of ghrelin occurred 90 min postprandially; however, maximal suppression occurred at 120 min after only 1 week of dietary supplementation. Earlier suppression was again noted after 3 weeks (P ¼ 0.001). Plasma leptin concentrations did not change postprandially during the OFTT. The mean leptin concentration was increased following 3 weeks of dietary supplementation (P ¼ 0.035) ( Table 1 ) and correlated to subjects BMI (r 2 ¼ 0.46; P ¼ 0.025). There was no relationship with postprandial ghrelin levels. Plasma PP levels peaked within 30 min during the OFTT (Figure 2 ) with significantly lower levels reached after 3 weeks of dietary supplementation (P ¼ 0.038).
Metabolites
Postprandial plasma TG concentrations were significantly changed by dietary supplementation (P ¼ 0.009) (Figure 3 ). 
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After 2 weeks there was a significantly greater postprandial TG response (P ¼ 0.022) and after 3 weeks this response became more rapid (P ¼ 0.014). Plasma NEFA levels were initially suppressed during the baseline OFTT before rising to above fasting concentrations (Figure 4a ). There was no statistically significant effect of supplementation on NEFA levels although there was a trend for the initial suppression in postprandial NEFA to reduce with time on the diet. The postprandial NEFA response (AUC) was found to be correlated with the postprandial PP response (r 2 ¼ 0.45; P ¼ 0.029).
Plasma OHB concentrations exhibited a similar pattern to that of NEFA (Figure 4b ). During the baseline OFTT, OHB levels are suppressed to below fasting concentrations however, after 2 weeks on the supplemented diet this suppression was absent. Postprandial OHB levels were found to be highly correlated with both plasma NEFA (r 2 ¼ 0.64; P ¼ 0.001) and plasma TG concentrations (r 2 ¼ 0.51; P ¼ 0.013) (AUCs).
Discussion
This pilot study was designed to investigate the sequential changes in the transit of a meal, metabolite responses and plasma gastrointestinal hormone levels during a period of acute overfeeding (3.9 MJ/day) with high-fat food. Elevated plasma TG concentrations are a common feature of obesity due to a combination of enhanced absorption of lipid, altered lipase activation and increased VLDL secretion due to increased hepatic flux of free fatty acids (from the lipolysis of chylomicron-TG). From day 1 of the high-fat supplemented diet, the gastrointestinal mucosa was exposed to higher concentrations of lipid and yet the plasma TG concentration is not increased until 14 days later although nonsignificant increases are observed after 1 week. Changes in the gastric emptying profile were observed after 1 week and precede the change in plasma TG, this is earlier than noted in other highfat feeding studies and may represent differences in gastricemptying methodologies. 9, 15 Plasma TG levels were elevated after 2 weeks and after 3 weeks an accelerated transport of lipid into the plasma was observed indicating changes in absorptive function over the 3-weeks of the study potentially due to more rapid entry of lipid into the duodenum.
In the study, we have demonstrated a significant increase in postprandial ghrelin suppression following oral fat following a relatively short-period of increased energy intake. Ghrelin has been shown to be reduced in obesity 7 and raised in anorexia nervosa, 16 an effect that could potentially reflect metabolic adaptation to long-term changes in energy intake. It has been suggested that ghrelin levels are responding to changes in body weight and not to changes in energy supplied to the GI tract, however, our results imply that the metabolic adaptation in circulating ghrelin concentrations noted in obesity may be more rapid than this and begin before significant increases in body weight. In controlled human studies, a diet-induced weight loss of 17% initial body weight has been associated with a 24% increase in ghrelin AUC 17 yet more recent work from the same group 11 has shown that when this weight-loss was achieved with a fat-restricted diet, ghrelin levels remained Ghrelin and overfeeding MD Robertson et al unchanged at the low level associated with obesity. In our study a weight gain of only 3% of initial body weight was associated with an 18% decrease in ghrelin AUC. It may be the case that GI adaptations resulting from changes in dietary fat intake are more sensitive to increased fat than reduced fat, which would have implications for weight loss following obesity. In rats, high-fat feeding has also been shown to reduce plasma ghrelin levels 18, 19 although the explanation is unclear as high-fat feeding has been shown to both reduce 18 and increase 20 gastric ghrelin mRNA levels. It is also not known whether this effect is due to increased exposure of the duodenal mucosa to lipid or secondary to the increased levels of another lipid-induced hormone such as cholecystokinin (CCK) as both plasma and mRNA levels of CCK have been shown to increase following a high-fat diet. 21 Lipid-induced inhibition of food intake and gastric emptying are dependent upon activation of vagal sensory fibres of the nucleus of the solitary tract and area postrema. 22 Following a high-fat diet in rats, activation of these hindbrain neurons is reduced 23 which may or may not be linked directly to the reduction in ghrelin levels 24 or in a degree to 'CCK-restistance'. 10 The finding that the gastric emptying rate was increased after 2 weeks demonstrates the time course for this gastric motility adaptation in humans but in itself is not a novel finding. 9, 15 What perhaps is more striking is the change in time course of both ghrelin and plasma TG. The increased gastric emptying rate at 2 weeks may be responsible for the more rapid suppression of plasma ghrelin and indeed a recent study conducted by our group has demonstrated that the gastric emptying rate, plasma TG and plasma ghrelin to be intrinsically linked. 25 Further work in which fat is placed directly into the duodenum is necessary to disseminate the effects of fat on gastric emptying and ghrelin suppression. There is no evidence to suggest that the ghrelin producing X/A cells of the duodenum are not responding directly to lipid contact, so a more rapid entry of lipid into the duodenum is likely to have an effect on hormone levels. It is hypothesised that the stimulatory effects of ghrelin and the inhibitory effects of leptin integrate in the regulation of feeding and energy expenditure via orexigenic peptides, however unlike ghrelin, plasma leptin concentrations do not change acutely during the postprandial period. 26 During perturbations in energy balance both plasma leptin concentrations and adipose tissue leptin mRNA 27, 28 have been shown to change independently of adipose tissue stores, consistent with our findings. Another candidate is pancreatic polypeptide (PP), a satiety factor released from the pancreas into the circulation by vagal-cholinergic mechanisms. We found PP to be significantly reduced following 3-weeks of supplementation, an effect previously only found in obese subjects. 29, 30 As the aim of the work was to study human subjects during the early phase of obesity development, volunteers in this study were not given the option to 'eat less' and so the true impact of the observed reduction in plasma ghrelin levels the development of obesity cannot be ascertained as appetite and voluntary food intake have an important role to play. We demonstrated in this pilot study that changes in the postprandial ghrelin response are sensitive to recent changes in energy intake although further work is necessary to determine if this simple observation explains the lower levels found in obese subjects. The metabolic profile that has previously been associated with obesity can develop in lean individuals following a short-term increase in energy intake before a significant gain in body weight; reduced plasma ghrelin, elevated leptin, reduced meal-stimulated PP, increased rate of gastric emptying and elevated plasma TG. The qualitative definition of obesity relies upon estimates of adiposity and body mass index but this work has demonstrated that the quantitative or metabolic definition of obesity can be moved closer to baseline by relatively short-periods of dietary excess.
